BSEBoard Meeting3 Nov 2026 · 3 Nov 2026, 08:41 pm

Dear Sir/Madam, This is to inform you that, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of the Company, at its meeting held today, i.e., Tuesday, November 03, 2026, through Video Conferencing, inter alia, considered and approved the following: 1. Un-Audited Standalone and Consolidated Financial Results for the Quarter and Half year ended ....

Deep Health AI India Ltd · 539559

✦ AI SummaryResults

Deep Health AI India Ltd has announced the outcome of its board meeting, where it considered and approved the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, along with a draft limited review report. The trading window for dealing in shares of the company has been closed for all directors, KMPs, designated employees, and connected persons from October 1, 2026, and will remain closed for 48 hours after the declaration of the financial results.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Deep Health AI India Ltd - 539559 - Board Meeting Outcome for Submission Of Outcome Of Board Meeting In Compliance With The Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations)

Attachments (1)

📄

b425367d-245f-4693-847e-df73fff54caa.pdf

pdf

Download →
View document text
DEEP HEALTH AI INDIA LIMITED (Formerly known as “Deep Diamond India Limited”) CIN: L24100RJ1994PLC112895 Regd. Office: 506-509 fifth floor, Apeksha, Plot No. 256, Main Road, Hiran Magri, Sector 11, Udaipur, Rajasthan (313001) Tel: 0294-3569097. E-mail: deephealthaiindia@gmail.com Website: www.deephealthaiindia.com Date: November 03, 2026 The Manager, BSE Limited Address: Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400001. Scrip Code: 539559 Subject: Submission of Outcome of Board Meeting in compliance with the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”). Dear Sir/Madam, This is to inform you that, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), the Board of Directors of the Company, at its meeting held today, i.e., Tuesday, November 03, 2026, through Video Conferencing, inter alia, considered and approved the following: 1. Un-Audited Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 2026, along with draft Limited Review Report pursuant to Regulation 33 of the Securities Exchange and Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further, the Trading Window for dealing in shares of the Company has already been closed for all Directors/ KMPs/Designated Employees/ Connected Person of the Company from October 01, 2026, and will remain closed up to 48 (Forty-Eight) hours after the declaration of Un-Audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026 (both days inclusive) in accordance with SEBI (Prohibition of Insider Trading) Regulation, 2015 and the Company’s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders. The Board Meeting commenced at 03:00 P.M and concluded at 07:35 P.M. Kindly take the same on your records. FOR DEEP HEALTH AI INDIA LIMITED (Formerly known as Deep Diamond India Limited) Narayan Singh Rathore Managing Director DIN: 10900646 Place: Udaipur